Author(s): Kohn R, Saxena S, Levav I, Saraceno B
Abstract Share this page
Abstract Mental disorders are highly prevalent and cause considerable suffering and disease burden. To compound this public health problem, many individuals with psychiatric disorders remain untreated although effective treatments exist. We examine the extent of this treatment gap. We reviewed community-based psychiatric epidemiology studies that used standardized diagnostic instruments and included data on the percentage of individuals receiving care for schizophrenia and other non-affective psychotic disorders, major depression, dysthymia, bipolar disorder, generalized anxiety disorder (GAD), panic disorder, obsessive-compulsive disorder (OCD), and alcohol abuse or dependence. The median rates of untreated cases of these disorders were calculated across the studies. Examples of the estimation of the treatment gap for WHO regions are also presented. Thirty-seven studies had information on service utilization. The median treatment gap for schizophrenia, including other non-affective psychosis, was 32.2\%. For other disorders the gap was: depression, 56.3\%; dysthymia, 56.0\%; bipolar disorder, 50.2\%; panic disorder, 55.9\%; GAD, 57.5\%; and OCD, 57.3\%. Alcohol abuse and dependence had the widest treatment gap at 78.1\%. The treatment gap for mental disorders is universally large, though it varies across regions. It is likely that the gap reported here is an underestimate due to the unavailability of community-based data from developing countries where services are scarcer. To address this major public health challenge, WHO has adopted in 2002 a global action programme that has been endorsed by the Member States.
This article was published in Bull World Health Organ
and referenced in Family Medicine & Medical Science Research